Skip to content
Facebook Instagram Linkedin

LifeScienceHistory.com

History made daily

  • Home
  • DirectoryExpand
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • News and History
  • Cartoons
  • Small World
  • Earth is a RockExpand
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
LifeScienceHistory.com
History made daily
Home / NIH - Page 10

NIH

Baricitinib in combination with remdesivir reduced time to recovery in hospitalized patients with COVID-19 in ACTT-2 Trial
Biotechnology | COVID-19 | NIH | Therapeutics

Baricitinib in combination with remdesivir reduced time to recovery in hospitalized patients with COVID-19 in ACTT-2 Trial

On Sept. 14, 2020, Eli Lilly and Incyte announced initial data from the Adaptive COVID-19 Treatment Trial (ACTT-2)…

Read More Baricitinib in combination with remdesivir reduced time to recovery in hospitalized patients with COVID-19 in ACTT-2 TrialContinue

NIH ACTIV initiative launched adaptive clinical trials of blood-clotting treatments for COVID-19
COVID-19 | Life Science History | NIH

NIH ACTIV initiative launched adaptive clinical trials of blood-clotting treatments for COVID-19

On Sept. 10, 2020, the NIH launched two of three adaptive Phase 3 clinical trials evaluating the safety…

Read More NIH ACTIV initiative launched adaptive clinical trials of blood-clotting treatments for COVID-19Continue

Study showed U.S. decline in awareness, treatment and control of high blood pressure
Diagnostics | NIH

Study showed U.S. decline in awareness, treatment and control of high blood pressure

On Sept. 9, 2020, the National Institutes of Health (NIH) announced that after nearly 15 years on an…

Read More Study showed U.S. decline in awareness, treatment and control of high blood pressureContinue

U.S. Government exercised option to purchase additional RAPIVAB from BioCryst for delivery to Strategic National Stockpile
Biotechnology | CDC | Infectious Disease | Influenza | NIH | Therapeutics

U.S. Government exercised option to purchase additional RAPIVAB from BioCryst for delivery to Strategic National Stockpile

On Sept. 3, 2020, BioCryst Pharmaceuticals announced that the U.S. Department of Health and Human Services (HHS) had…

Read More U.S. Government exercised option to purchase additional RAPIVAB from BioCryst for delivery to Strategic National StockpileContinue

Lenzilumab COVID-19 case-control study published in Mayo Clinic Proceedings Journal
Biotechnology | COVID-19 | Infectious Disease | NIH | Therapeutics

Lenzilumab COVID-19 case-control study published in Mayo Clinic Proceedings Journal

On Sept. 3, 2020, Humanigen announced the first case-control data of lenzilumab in severe COVID-19 demonstrated an 80%…

Read More Lenzilumab COVID-19 case-control study published in Mayo Clinic Proceedings JournalContinue

Sonic Healthcare expand COVID-19 testing capacity in US in collaboration with NIH RADx Initiative
COVID-19 | Life Science History | NIH

Sonic Healthcare expand COVID-19 testing capacity in US in collaboration with NIH RADx Initiative

On Sept. 2, 2020, Sonic Healthcare USA was awarded a contract from the National Institutes of Health (NIH)…

Read More Sonic Healthcare expand COVID-19 testing capacity in US in collaboration with NIH RADx InitiativeContinue

Ceres received $65M NIH award to expand Nanotrapᆴ particle manufacturing capacity for COVID-19 testing
COVID-19 | Life Science History | NIH

Ceres received $65M NIH award to expand Nanotrapᆴ particle manufacturing capacity for COVID-19 testing

On Sept. 2, 2020, Ceres Nanosciences announced it had been awarded a contract from the National Institutes of…

Read More Ceres received $65M NIH award to expand Nanotrapᆴ particle manufacturing capacity for COVID-19 testingContinue

NIH awarded MicroGEM $409 million to fast-track rapid, no-lab COVID-19 saliva test
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Influenza | NIH

NIH awarded MicroGEM $409 million to fast-track rapid, no-lab COVID-19 saliva test

On Sept. 2, 2020, MicroGEM announced it had been awarded up to $40.9 million by the National Institutes…

Read More NIH awarded MicroGEM $409 million to fast-track rapid, no-lab COVID-19 saliva testContinue

NIH to boost national COVID-19 testing capacity
COVID-19 | Life Science History | NIH

NIH to boost national COVID-19 testing capacity

On Sept. 2, 2020, the NIH announced $129.3 million in scale-up and manufacturing support for a new set…

Read More NIH to boost national COVID-19 testing capacityContinue

Aegis Sciences awarded $66 million NIH grant to rapidly expand COVID-19 test capacity
COVID-19 | Life Science History | NIH

Aegis Sciences awarded $66 million NIH grant to rapidly expand COVID-19 test capacity

On Sept. 2, 2020, Aegis Sciences annunced that it had been selected to participate in the National Institutes…

Read More Aegis Sciences awarded $66 million NIH grant to rapidly expand COVID-19 test capacityContinue

PathGroup selected by NIH to become RADx program ‘mega-lab’ for COVID-19 testing
Biotechnology | COVID-19 | NIH

PathGroup selected by NIH to become RADx program ‘mega-lab’ for COVID-19 testing

On Sept. 2, 2020, PathGroup announced the award of a funding grant from the National Institutes of Health…

Read More PathGroup selected by NIH to become RADx program ‘mega-lab’ for COVID-19 testingContinue

New gene associated with reduced risk for cirrhosis
Biotechnology | Diagnostics | Disease | NIH

New gene associated with reduced risk for cirrhosis

On Aug. 31, 2020, an international team of scientists supported by the National Institutes of Health (NIH) announced…

Read More New gene associated with reduced risk for cirrhosisContinue

NIAID awarded BioCryst  $44 million contract to advance development of galidesivir
Disease | NIH | Therapeutics

NIAID awarded BioCryst $44 million contract to advance development of galidesivir

On Aug. 31, 2020, BioCryst Pharmaceuticals announced that the National Institute of Allergy and Infectious Diseases (NIAID) had…

Read More NIAID awarded BioCryst $44 million contract to advance development of galidesivirContinue

NIH established Centers for Research in Emerging Infectious Diseases
Biotechnology | Disease | NIH | Non-Profit Research

NIH established Centers for Research in Emerging Infectious Diseases

On Aug. 27, 2020, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes…

Read More NIH established Centers for Research in Emerging Infectious DiseasesContinue

Vaccitech received government grant for COVID-19 vaccine research
COVID-19 | NIH

Vaccitech received government grant for COVID-19 vaccine research

On Aug. 27, 2020, Vaccitech announced that it had received a non-dilutive Government grant to support research with…

Read More Vaccitech received government grant for COVID-19 vaccine researchContinue

White House announced plan to deploy 150 million rapid tests in 2020
Biotechnology | COVID-19 | Diagnostics | NIH

White House announced plan to deploy 150 million rapid tests in 2020

On Aug. 27, 2020, the U.S. Departments of Health and Human Services and the Department of and Defense…

Read More White House announced plan to deploy 150 million rapid tests in 2020Continue

La Jolla Institute for Immunology awarded $6.4 million for international efforts to beat COVID-19
Biotechnology | COVID-19 | Disease | Medicine | NIH | Therapeutics

La Jolla Institute for Immunology awarded $6.4 million for international efforts to beat COVID-19

On Aug. 20, 2020, the National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes…

Read More La Jolla Institute for Immunology awarded $6.4 million for international efforts to beat COVID-19Continue

NIH imposed ‘outrageous’ conditions on resuming coronavirus grants
COVID-19 | NIH

NIH imposed ‘outrageous’ conditions on resuming coronavirus grants

On Aug. 19, 2020, the National Institutes of Health (NIH) began requiring a small nonprofit research organization to…

Read More NIH imposed ‘outrageous’ conditions on resuming coronavirus grantsContinue

Mapping tool highlights NIH-funded small business successes
Life Science History | NIH

Mapping tool highlights NIH-funded small business successes

On Aug. 13, 2020, the NIH announced a new interactive mapping tool that showcases just some of the…

Read More Mapping tool highlights NIH-funded small business successesContinue

Celdara Medical announced receipt of NIH funding for pandemic influenza antiviral development
Biotechnology | COVID-19 | Influenza | NIH

Celdara Medical announced receipt of NIH funding for pandemic influenza antiviral development

On Aug. 12, 2020, Celdara Medical announced that the NIH had awarded a Small Business Innovation Research (SBIR)…

Read More Celdara Medical announced receipt of NIH funding for pandemic influenza antiviral developmentContinue

NIH harnessed AI for COVID-19 diagnosis, treatment, and monitoring
COVID-19 | Diagnostics | Medical Device | NIH

NIH harnessed AI for COVID-19 diagnosis, treatment, and monitoring

On Aug. 5, 2020, the National Institutes of Health (NIH) announced it had launched the Medical Imaging and…

Read More NIH harnessed AI for COVID-19 diagnosis, treatment, and monitoringContinue

NIH launched clinical trial to test antibody treatment in hospitalized COVID-19 patients
COVID-19 | Life Science History | NIH

NIH launched clinical trial to test antibody treatment in hospitalized COVID-19 patients

On Aug. 4, 2020, the NIH announced that patients admitted with COVID-19 at select hospitals may now volunteer…

Read More NIH launched clinical trial to test antibody treatment in hospitalized COVID-19 patientsContinue

Quidel received NIH contract for $71 million to expand manufacturing capacity for Sofia SARS-CoV-2 antigen test for diagnosis of COVID-19
Biotechnology | COVID-19 | NIH

Quidel received NIH contract for $71 million to expand manufacturing capacity for Sofia SARS-CoV-2 antigen test for diagnosis of COVID-19

On Jul. 31, 2020, Quidel announced a preliminary contract with the NIH to support the expansion of its…

Read More Quidel received NIH contract for $71 million to expand manufacturing capacity for Sofia SARS-CoV-2 antigen test for diagnosis of COVID-19Continue

Mesa Biotech announced $154 million funding from the NIH for Accelerated scale-up and deployment
COVID-19 | Diagnostics | NIH

Mesa Biotech announced $154 million funding from the NIH for Accelerated scale-up and deployment

On Jul. 31, 2020, Mesa Biotech announced it had been awarded a contract up to $15.4 million from…

Read More Mesa Biotech announced $154 million funding from the NIH for Accelerated scale-up and deploymentContinue

NIH delivered new COVID-19 testing technologies to meet US demand
COVID-19 | Life Science History | NIH

NIH delivered new COVID-19 testing technologies to meet US demand

On Jul. 31, 2020, the NIH announced that it had invested $248.7 million in new technologies to address…

Read More NIH delivered new COVID-19 testing technologies to meet US demandContinue

NIH invested $58 million to catalyze data science and health research innovation in Africa
Life Science History | NIH

NIH invested $58 million to catalyze data science and health research innovation in Africa

On Jul. 27, 2020, the NIH launched a $58 million initiative to advance data science, catalyze innovation and…

Read More NIH invested $58 million to catalyze data science and health research innovation in AfricaContinue

National Institutes of Health selected Humanigen’s lenzilumab for its COVID-19 Big Effect Trial
Biotechnology | COVID-19 | NIH | Therapeutics

National Institutes of Health selected Humanigen’s lenzilumab for its COVID-19 Big Effect Trial

On Jul. 27, 2020, Humanigen announced that the National Institute of Allergy and Infectious Diseases and Humanigen had…

Read More National Institutes of Health selected Humanigen’s lenzilumab for its COVID-19 Big Effect TrialContinue

Onconova Therapeutics submitted application for rigosertib to participate in federally funded human studies in COVID-19 disease
Biotechnology | COVID-19 | NIH | Therapeutics

Onconova Therapeutics submitted application for rigosertib to participate in federally funded human studies in COVID-19 disease

On Jul. 27, 2020, Onconova Therapeutics announced that it had submitted an application with the National Institute of…

Read More Onconova Therapeutics submitted application for rigosertib to participate in federally funded human studies in COVID-19 diseaseContinue

Preclinical study showed SARS-CoV-2 spike protein licensed by Oragenics from NIH produces neutralizing antibodies
COVID-19 | Life Science History | NIH

Preclinical study showed SARS-CoV-2 spike protein licensed by Oragenics from NIH produces neutralizing antibodies

On Jul. 22, 2020, Oragenics announced that the National Institutes of Health created stabilized pre-fusion spike protein (CoV-2…

Read More Preclinical study showed SARS-CoV-2 spike protein licensed by Oragenics from NIH produces neutralizing antibodiesContinue

Experimental Coronavirus vaccine is safe and produced immune response
Biotechnology | COVID-19 | Infectious Disease | NIH | Vaccine

Experimental Coronavirus vaccine is safe and produced immune response

On Jul. 21, 2020, National Institutes of Health (NIH) researchers reported early results from the first COVID-19 vaccine…

Read More Experimental Coronavirus vaccine is safe and produced immune responseContinue

Page navigation

Previous PagePrevious 1 … 8 9 10 11 12 … 24 Next PageNext
  • Categories
  • Timeline
  • Agriculture
  • Artificial Intelligence
  • Biology
  • Biotechnology
  • Cardiology
  • Cartoons – Historical
  • Cartoons – Original
  • CDC
  • CDMO
  • Chemistry
  • Clinical Research
  • Cloning
  • CMO
  • COVID-19
  • CRISPR
  • CRO
  • Cryogenic
  • Dentistry
  • Diagnostics
  • Disease
  • Energy
  • Environmental
  • EPA
  • FDA
  • Forestry
  • Genomics
  • HIV
  • Infectious Disease
  • Influenza
  • IRB
  • Life Science History
  • Marine Science
  • Materials
  • Measles
  • Medical Device
  • Medicine
  • Nanotechnology
  • Neurology
  • NIH
  • Non-Profit Research
  • Nutraceuticals
  • Oncology
  • Ophthalmogy
  • Organ Transplant
  • Orthopedic
  • Other
  • Pharmaceutical
  • Plague
  • Polio
  • Prehistory
  • Radiology
  • Rare Disease
  • Stem Cell
  • Therapeutics
  • U.S. Congress
  • Uncategorized
  • USDA
  • Vaccine
  • Veterinary
  • WHO
  • Women's Health
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
  • 1966
  • 1965
  • 1964
  • 1963
  • 1962
  • 1961
  • 1960
  • 1959
  • 1958
  • 1957
  • 1956
  • 1955
  • 1954
  • 1953
  • 1952
  • 1951
  • 1950
  • 1949
  • 1948
  • 1947
  • 1946
  • 1945
  • 1944
  • 1943
  • 1942
  • 1941
  • 1940
  • 1939
  • 1938
  • 1937
  • 1936
  • 1935
  • 1934
  • 1933
  • 1932
  • 1931
  • 1930
  • 1929
  • 1928
  • 1927
  • 1926
  • 1925
  • 1924
  • 1923
  • 1922
  • 1921
  • 1920
  • 1919
  • 1918
  • 1917
  • 1916
  • 1915
  • 1914
  • 1913
  • 1912
  • 1911
  • 1910
  • 1909
  • 1908
  • 1907
  • 1906
  • 1905
  • 1904
  • 1903
  • 1902
  • 1901
  • 1900
  • 1899
  • 1898
  • 1897
  • 1896
  • 1895
  • 1894
  • 1893
  • 1892
  • 1891
  • 1890
  • 1889
  • 1888
  • 1887
  • 1886
  • 1885
  • 1884
  • 1883
  • 1882
  • 1881
  • 1880
  • 1879
  • 1878
  • 1877
  • 1876
  • 1875
  • 1874
  • 1873
  • 1872
  • 1871
  • 1870
  • 1869
  • 1868
  • 1867
  • 1866
  • 1865
  • 1864
  • 1863
  • 1862
  • 1861
  • 1860
  • 1859
  • 1858
  • 1857
  • 1856
  • 1855
  • 1854
  • 1853
  • 1852
  • 1851
  • 1850
  • 1849
  • 1848
  • 1847
  • 1846
  • 1845
  • 1844
  • 1843
  • 1842
  • 1840
  • 1839
  • 1838
  • 1837
  • 1836
  • 1834
  • 1833
  • 1832
  • 1831
  • 1830
  • 1828
  • 1827
  • 1826
  • 1825
  • 1824
  • 1823
  • 1820
  • 1819
  • 1818
  • 1817
  • 1816
  • 1813
  • 1811
  • 1810
  • 1809
  • 1808
  • 1804
  • 1802
  • 1801
  • 1800
  • 1799
  • 1798
  • 1796
  • 1795
  • 1794
  • 1793
  • 1790
  • 1789
  • 1788
  • 1786
  • 1785
  • 1784
  • 1782
  • 1781
  • 1777
  • 1769
  • 1765
  • 1761
  • 1753
  • 1751
  • 1749
  • 1747
  • 1746
  • 1743
  • 1741
  • 1738
  • 1727
  • 1723
  • 1721
  • 1720
  • 1718
  • 1716
  • 1712
  • 1697
  • 1693
  • 1683
  • 1674
  • 1667
  • 1666
  • 1665
  • 1664
  • 1663
  • 1658
  • 1656
  • 1647
  • 1636
  • 1634
  • 1629
  • 1621
  • 1603
  • 1580
  • 1521
  • 1510
  • 1403
  • 1377
  • 1370
  • 1363
  • 1348
  • 1346
  • 1322
  • 1285
  • 1202
  • 1200
  • 1179
  • 1100
  • 1050
  • 541
  • 470
  • 1
Subscribe to E-History

Subscribe

* indicates required

LifeScienceHistory.com

LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data.

More

  • About
  • Life Science Heroes

Advertising

  • Banner Advertising

Legal

  • Privacy Policy
  • Terms of Use

© 2025 LifeScienceHistory.com by James Web Design

Facebook Instagram Linkedin
  • Home
  • Directory
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • News and History
  • Cartoons
  • Small World
  • Earth is a Rock
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
Search